谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Frontline Brentuximab Vedotin and CHP (A+CHP) in Patients (pts) with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression: Results from the Phase 2 SGN35-032 Study.

Swaminathan Padmanabhan Iyer,Deepa Jagadeesh,Eva Domingo-Domenech,Fabio Benedetti,Antonia Rodriguez Izquierdo,Krimo Bouabdallah,Umberto Vitolo,Tim M. Illidge,Jingmin Liu, Eeman Shaikh,Steven M. Horwitz

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要